Allucent is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. The company is purpose-built through the convergence of leading providers to address this unmet need. Today, Allucent is a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics and clinical pharmacology across a variety of therapeutic areas. With more than 30 years of experience in over 60 countries, Allucent’s individualized partnership approach provides experience-driven insights and expertise to assist its clients in successfully navigating the complexities of delivering novel treatments to patients.
clinical pharmacology, pharmacokinetics, central nervous system, patient recruitment, ndablamaa, small & midsized biotech companies, product development, study start up feasibility, regulatory strategy, oncology hematology, study startup feasibility, medical monitoring, regulatory affairs & submissions, biostatistics, pharmacovigilance, clinical strategy, rare diseases orphan indications, protocol & study design, data management, oncology, drug development, cell gene therapy, gastroenterology hepatology, medicalscientific writing